Research

Mammographic Density in Postmenopausal Women

February 3, 2026

Resources

4a.patent-reducingRiskBreastCancer
4b.mhraAuthorizesEnzymeInhibitor

Summary

High mammographic density in postmenopausal women is a significant, independent risk factor for breast cancer, often associated with a 2 to 5 times greater risk for those with

≥ 50% dense tissue. While density typically decreases after menopause, persistent high density indicates higher risk. Postmenopausal hormone therapy (HT) can increase density and further elevate risk.       

Key Findings on Density and Risk in Postmenopause:

  • Strong Risk Marker: High breast density is a top predictor of breast cancer risk, comparable to age or family history, and it is not solely due to the difficulty of detecting tumors on mammograms.
  • Impact of Hormone Therapy (HT): Postmenopausal women using estrogen plus progestin often have higher breast density and higher cancer risk compared to those not using HT.
  • Changing Density: Breast density generally decreases with age due to involution, where glandular tissue is replaced by fat, which usually lowers risk. If density remains high, the risk remains higher.
  • Risk Magnitude: Postmenopausal women with 50% or more dense breast tissue have a significantly higher risk compared to those with low density (e.g., < 10%).
  • Combination Risks: Higher density combined with other factors, such as high BMI or HT, further increases the risk of developing breast cancer.                                             

Management and Considerations:

  • Detection Challenges: Dense tissue appears white on a mammogram, similar to tumors, which can mask cancers, reducing the sensitivity of mammography.

Modifiable Risk: Treatments like tamoxifen or stopping hormone therapy can reduce breast density and lower associated risk.